In vitro and in vivo experiments have demonstrated that PNS can alleviate diseases caused by AD risk factors by modulating HPA axis disorders, lowering excess free FFA levels, improving insulin resistance, and promoting vascular wall thickening to reduce Aβ accumulation and Tau hyperphosphorylation in the brain (Wu et al., 2024). Here, MAPT is linked to Alzheimer disease.